ZA200806382B - Purification and use of a factor for supporting wound healing - Google Patents

Purification and use of a factor for supporting wound healing

Info

Publication number
ZA200806382B
ZA200806382B ZA200806382A ZA200806382A ZA200806382B ZA 200806382 B ZA200806382 B ZA 200806382B ZA 200806382 A ZA200806382 A ZA 200806382A ZA 200806382 A ZA200806382 A ZA 200806382A ZA 200806382 B ZA200806382 B ZA 200806382B
Authority
ZA
South Africa
Prior art keywords
purification
factor
wound healing
supporting wound
supporting
Prior art date
Application number
ZA200806382A
Other languages
English (en)
Inventor
Neisser-Svae Andrea
Mjaerdestam Anna
Winge Stefan
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of ZA200806382B publication Critical patent/ZA200806382B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/49—Platelet-derived growth factor [PDGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA200806382A 2006-01-25 2008-07-23 Purification and use of a factor for supporting wound healing ZA200806382B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06100819 2006-01-25

Publications (1)

Publication Number Publication Date
ZA200806382B true ZA200806382B (en) 2009-06-24

Family

ID=36607451

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200806382A ZA200806382B (en) 2006-01-25 2008-07-23 Purification and use of a factor for supporting wound healing

Country Status (14)

Country Link
US (1) US8962813B2 (xx)
EP (1) EP1987054A1 (xx)
JP (1) JP2009524622A (xx)
KR (1) KR20080088610A (xx)
CN (1) CN101374855A (xx)
AU (1) AU2007209363B2 (xx)
BR (1) BRPI0707268A2 (xx)
CA (1) CA2640010A1 (xx)
IL (1) IL192320A0 (xx)
NO (1) NO20082787L (xx)
RU (1) RU2520817C2 (xx)
UA (1) UA94442C2 (xx)
WO (1) WO2007085626A1 (xx)
ZA (1) ZA200806382B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7935364B2 (en) * 2008-03-04 2011-05-03 Wisconsin Alumni Research Foundation Patterned gradient wound dressing and methods of using same to promote wound healing
DE102009029194A1 (de) * 2009-09-04 2011-04-07 Kimberly-Clark Worldwide, Inc., Neenah Abtrennung gefärbter Stoffe aus wasserhaltigen Flüssigkeiten
WO2011028173A1 (en) * 2009-09-05 2011-03-10 Fariba Nayeri Method of treatment of a patient suffering from an infection or injuries caused or complicated by infection
AU2010202125B1 (en) * 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
US8796430B2 (en) 2010-05-26 2014-08-05 Baxter International Inc. Method to produce an immunoglobulin preparation with improved yield
US8772462B2 (en) 2010-05-26 2014-07-08 Baxter International Inc. Removal of serine proteases by treatment with finely divided silicon dioxide
IL210162A0 (en) * 2010-12-21 2011-03-31 Omrix Biopharmaceuticals Viral inactivated platelet extract, use and preparation thereof
TR201807926T4 (tr) 2011-02-04 2018-06-21 Octapharma Ag Koagülasyon faktörlerinin çökeltme yoluyla etkisizleştirilmesine/çıkarılmasına yönelik usul.
WO2013077641A1 (ko) * 2011-11-22 2013-05-30 (주)아모레퍼시픽 성장 인자를 포함하는 피부 재생 촉진제
US9161869B2 (en) 2012-03-30 2015-10-20 Kimberly-Clark Worldwide, Inc. Absorbent articles with decolorizing agents
US9237975B2 (en) 2013-09-27 2016-01-19 Kimberly-Clark Worldwide, Inc. Absorbent article with side barriers and decolorizing agents
US10239926B2 (en) 2015-02-27 2019-03-26 The University Of Vermont And State Agriculture College Compositions and methods for vascular protection against reperfusion injury after myocardial ischemia
EP3334441B1 (en) 2015-08-13 2021-06-16 Kamada Ltd. Compositions derived from cohn fraction paste and use thereof
CN105797205B (zh) * 2016-04-20 2018-08-31 江苏迈健生物科技发展股份有限公司 干细胞培养上清凝胶及其制备方法
CN107216384A (zh) * 2017-05-11 2017-09-29 深圳市卫光生物制品股份有限公司 一种人血浆转铁蛋白分离纯化的方法
US10836790B1 (en) * 2019-09-20 2020-11-17 Plasma Technologies, Llc Therapeutic protein compositions and methods
US20210087224A1 (en) * 2019-09-20 2021-03-25 Plasma Technologies, Llc Compositions and methods for generating modified cryo poor plasma

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6045534A (ja) * 1983-08-22 1985-03-12 Otsuka Pharmaceut Co Ltd 肝実質細胞増殖因子
JPS60243019A (ja) * 1984-05-17 1985-12-03 Mitsubishi Chem Ind Ltd 肝細胞増殖因子
US4673733A (en) * 1985-04-11 1987-06-16 Sudhish Chandra Treatment of biological and pharmaceutical products adsorbed on a solid phase with virus and pyrogen inactivating agents
US4839298A (en) * 1986-02-14 1989-06-13 Akzo N.V. Virus inactivating diluents used in immunoassays
JP2564486B2 (ja) * 1986-07-14 1996-12-18 修治 橋本 肝細胞増殖因子
NZ232813A (en) * 1989-03-10 1992-08-26 Snow Brand Milk Products Co Ltd Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons
GB9110202D0 (en) * 1991-05-10 1991-07-03 Erba Carlo Spa Truncated forms of the hepatocyte growth factor(hgf)receptor
US5348941A (en) * 1992-04-01 1994-09-20 Merck & Co., Inc. Stabilizers for fibroblast growth factors
AUPN858596A0 (en) * 1996-03-08 1996-04-04 Csl Limited Filtration of plasma precipitates using cellulose filter aid
SE0000178D0 (sv) * 2000-01-21 2000-01-21 Pharmacia & Upjohn Ab Protein purification I
US6451978B2 (en) * 2000-01-21 2002-09-17 Biovitrum Ab Purification of antithrombin-III-α and β
AU2006259408A1 (en) * 2005-06-17 2006-12-28 Genentech, Inc. Use of VEGF for wound healing

Also Published As

Publication number Publication date
US8962813B2 (en) 2015-02-24
BRPI0707268A2 (pt) 2011-04-26
CN101374855A (zh) 2009-02-25
AU2007209363A1 (en) 2007-08-02
WO2007085626A1 (en) 2007-08-02
JP2009524622A (ja) 2009-07-02
NO20082787L (no) 2008-10-13
UA94442C2 (ru) 2011-05-10
CA2640010A1 (en) 2007-08-02
EP1987054A1 (en) 2008-11-05
RU2520817C2 (ru) 2014-06-27
IL192320A0 (en) 2008-12-29
KR20080088610A (ko) 2008-10-02
RU2008134479A (ru) 2010-02-27
US20100261651A9 (en) 2010-10-14
AU2007209363B2 (en) 2013-08-22
US20090221491A1 (en) 2009-09-03

Similar Documents

Publication Publication Date Title
IL192320A0 (en) Purification and use of a factor for supporting wound healing
EP1981457A4 (en) SURGICAL DRESSING
GB0625963D0 (en) Medicaments and methods for wound healing
GB0608437D0 (en) Wound dressings
ZA200808336B (en) Multi-layer wound dressings
EP2083876A4 (en) WOUND CARE AND TREATMENT METHOD
IL231461A (en) A wound care system
GB2444549B (en) Limb support
PL1983950T3 (pl) Opatrunek
GB0601928D0 (en) Wound dressing
EP2195025A4 (en) THERAPEUTIC ANTIBODY PURIFICATION METHOD AND METHOD OF USE
GB0625965D0 (en) Medicaments for wound healing
EP1899475A4 (en) COMPOSITION USED IN WOUND HEALING AND USE THEREOF
GB2435425B (en) Medical wound healing treatment
GB0603630D0 (en) Medical wound healing treatment
PL2244724T3 (pl) Zastosowanie peptydów do poprawy gojenia się rany
GB0625966D0 (en) Medicaments and methods for promoting wound contraction
EP2120967A4 (en) METHOD FOR PROMOTING HEALING OF INJURIES
GB0820032D0 (en) Wound dressings and materials suitable for use therein
ZA200800177B (en) A composition for wound healing and use thereof
ZA200904476B (en) Wound bed preparation
GB0622694D0 (en) Use of opioid compounds in wound healing
GB2444703B (en) Wound dressing
GB0403786D0 (en) Liquid bandages for burn and wound treatment
GB0625964D0 (en) Promotion of wound contraction